That's good tuks, we are on the same wavelength re IO established data for percents success for historical
research.....In my mind with the advent of computer diagnosis and AI (artificial intelligence) to its standards
of today and what progress it evolves to futurewise will make it nigh on impossible to formulate a
retrospective research base to actually itemise a percentile success rate that is still relevant in the
immunotherapy sector.....
Echo your thoughts re HIV, Mathieu Angin is not at Immutep to do the gardening, HIV is his speciality..
eerily comfortable....., page-18
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $480.0M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 32.0¢ | $1.703M | 5.215M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 211685 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 279000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |